{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:49:21Z","timestamp":1782344961736,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CTS981"],"award-info":[{"award-number":["CTS981"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00505"],"award-info":[{"award-number":["PI20\/00505"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00453"],"award-info":[{"award-number":["PI18\/00453"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01104"],"award-info":[{"award-number":["PI17\/01104"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00171"],"award-info":[{"award-number":["PI23\/00171"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116508","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T01:04:00Z","timestamp":1712192640000},"page":"116508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RNA expression changes driven by altered epigenetics status related to NASH etiology"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-8244","authenticated-orcid":false,"given":"Daniel","family":"Castellano-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ramos-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Arranz-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Reyes-Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2867-0845","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Queipo-Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116508_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116508_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116508_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01763-z","article-title":"Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol","volume":"21","author":"Nasr","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116508_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13054","article-title":"Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseases","volume":"21","author":"Castellano-Castillo","year":"2020","journal-title":"Obes. Rev."},{"key":"10.1016\/j.biopha.2024.116508_bib5","doi-asserted-by":"crossref","unstructured":"V. Woo, T. Alenghat, Epigenetic regulation by gut microbiota, (2022). https:\/\/doi.org\/10.1080\/19490976.2021.2022407.","DOI":"10.1080\/19490976.2021.2022407"},{"key":"10.1016\/j.biopha.2024.116508_bib6","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1074\/jbc.TM118.000831","article-title":"The role of \u03b1-ketoglutarate\u2013dependent proteins in pluripotency acquisition and maintenance","volume":"294","author":"Tran","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116508_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2024.116508_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2024.116508_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116508_bib10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116508_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-020-1929-3","article-title":"From reads to insight: a hitchhiker\u2019s guide to ATAC-seq data analysis","volume":"21","author":"Yan","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2024.116508_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13072-020-00342-y","article-title":"ATAC-seq normalization method can significantly affect differential accessibility analysis and interpretation","volume":"13","author":"Reske","year":"2020","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.biopha.2024.116508_bib13","first-page":"D58","article-title":"EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue\/cell types across nine species","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116508_bib14","doi-asserted-by":"crossref","first-page":"D164","DOI":"10.1093\/nar\/gkv1002","article-title":"dbSUPER: a database of super-enhancers in mouse and human genome","volume":"44","author":"Khan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116508_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.116508_bib16","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1158\/1078-0432.CCR-21-3467","article-title":"Impact of venetoclax and azacitidine in treatment-na\u00efve patients with acute Myeloid Leukemia and IDH1\/2 mutations","volume":"28","author":"Pollyea","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116508_bib17","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1016\/S2352-3026(22)00216-2","article-title":"Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1\u20132 study","volume":"9","author":"Bazinet","year":"2022","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.biopha.2024.116508_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s12185-023-03561-7","article-title":"Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation","author":"Tao","year":"2023","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.biopha.2024.116508_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00280-023-04511-0","article-title":"Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies","volume":"91","author":"Shafer","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116508_bib20","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1002\/jcp.26278","article-title":"Exercise increases Rho-kinase activity and insulin signaling in skeletal muscle","volume":"233","author":"Mu\u00f1oz","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2024.116508_bib21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","article-title":"Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease","volume":"472","author":"Chadt","year":"2020","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.biopha.2024.116508_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","article-title":"AMPK re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development","volume":"28","author":"Boudaba","year":"2018","journal-title":"EBioMedicine"},{"issue":"80-.","key":"10.1016\/j.biopha.2024.116508_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK\u2013caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.116508_bib24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/jcb.30274","article-title":"Targeting the lysosome: mechanisms and treatments for nonalcoholic fatty liver disease","volume":"123","author":"Pu","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2024.116508_bib25","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-17-0002","article-title":"FoxO integration of insulin signaling with glucose and lipid metabolism","volume":"233","author":"Lee","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116508_bib26","first-page":"1","article-title":"FOXO transcription factors protect against the diet-induced fatty liver disease","volume":"7","author":"Pan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116508_bib27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.14218\/JCTH.2017.00061","article-title":"Role of SREBPs in liver diseases: a mini-review","volume":"6","author":"Moslehi","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.biopha.2024.116508_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2010.04.033","article-title":"Down-regulation of SREBP-1c is associated with the development of burned-out NASH","volume":"53","author":"Nagaya","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116508_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42004-020-00411-z","article-title":"A triple farnesoid X receptor and peroxisome proliferator-activated receptor \u03b1\/\u03b4 activator reverses hepatic fibrosis in diet-induced NASH in mice","volume":"3","author":"Heitel","year":"2020","journal-title":"Commun. Chem."},{"key":"10.1016\/j.biopha.2024.116508_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.06.003","article-title":"SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice","volume":"81","author":"Nguyen","year":"2021","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2024.116508_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41580-018-0029-7","article-title":"Regulation of chromatin and gene expression by metabolic enzymes and metabolites","author":"Li","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116508_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103233","article-title":"Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver","volume":"24","author":"Su","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.biopha.2024.116508_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116508_bib34","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.biopha.2024.116508_bib35","doi-asserted-by":"crossref","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2024.116508_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2024.116508_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12272-023-01441-6","article-title":"Regulation of NOX\/p38 MAPK\/PPAR\u03b1 pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight","volume":"46","author":"Salama","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2024.116508_bib38","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.3748\/wjg.v27.i25.3863","article-title":"PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.","volume":"27","author":"Zhang","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116508_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12944-021-01461-5","article-title":"Elucidation of SIRT-1\/PGC-1\u03b1-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease","volume":"20","author":"Jiang","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2024.116508_bib40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)64614-7","article-title":"Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency","volume":"157","author":"Christiansen-Weber","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.116508_bib41","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.celrep.2017.05.032","article-title":"Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis","volume":"19","author":"Key","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116508_bib42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s11010-022-04618-7","article-title":"Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders","volume":"478","author":"Akhtar","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2024.116508_bib43","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hep.32289","article-title":"Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance","volume":"75","author":"Remetic","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116508_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200083119","article-title":"Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease","volume":"119","author":"Jouffe","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.116508_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41401-021-00658-9","article-title":"Bmal1 inhibits phenotypic transformation of hepatic stellate cells in liver fibrosis via IDH1\/\u03b1-KG-mediated glycolysis","volume":"43","author":"Xu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2024.116508_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0272-z","article-title":"The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity","volume":"9","author":"Mellado-Gil","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116508_bib47","first-page":"4178","article-title":"Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116508_bib48","first-page":"1","article-title":"FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models","author":"O\u2019Farrell","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116508_bib49","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN Inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a Trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116508_bib50","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1002\/jcp.27474","article-title":"Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis","volume":"234","author":"Dom\u00ednguez-P\u00e9rez","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2024.116508_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2021.03.006","article-title":"The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis","volume":"75","author":"An","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116508_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1019405","article-title":"Ubiquitin-like processing of TUG proteins as a mechanism to regulate glucose uptake and energy metabolism in fat and muscle OPEN ACCESS EDITED BY","volume":"13","author":"Bogan","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116508_bib53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nature01989","article-title":"Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking","volume":"425","author":"Bogan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116508_bib54","doi-asserted-by":"crossref","first-page":"25704","DOI":"10.1074\/jbc.M109.023846","article-title":"The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice","volume":"284","author":"Fullerton","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116508_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-05140-y","article-title":"Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine","volume":"12","author":"Grapentine","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116508_bib56","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.1007\/s13277-016-5302-9","article-title":"Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients","volume":"37","author":"Hang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2024.116508_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09418-0","article-title":"FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism","volume":"10","author":"Sakaguchi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116508_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2024.116508_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2013.11.081","article-title":"Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity","volume":"537","author":"Remely","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2024.116508_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA Methylation in the Mammalian Genome","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.116508_bib61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2017.09.006","article-title":"CRISPR\/Cas9-based engineering of the epigenome","volume":"21","author":"Pulecio","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2024.116508_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13072-019-0275-8","article-title":"Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner","volume":"12","author":"O\u2019Geen","year":"2019","journal-title":"Epigenetics Chromatin"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:22:10Z","timestamp":1782343330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":62,"alternative-id":["S0753332224003925"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116508","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA expression changes driven by altered epigenetics status related to NASH etiology","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116508"}}